Fabrice AGOU
Head of Chemogenomic and Biological screening core facility
FranceResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Fabrice Agou is the Head of Chemogenomic and Biological Screening Core Facility at Institut Pasteur, France. His research primarily focuses on the inhibition of TDP-43 aggregation, the development of SARS-CoV-2 inhibitors, and the role of ubiquitin-related enzymes in cytokinesis. His recent publications reflect his expertise in high-content screening techniques and the therapeutic potential of antibodies against viral variants.
Articles (10)
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Collaborators (12)
Yann GAMBIN
UNSW Sydney
Haitham Hassan
Lecturer in Medicinal Chemistry & Drug Discovery
University of Sussex
David Courtney
The Queen's University Belfast
Emma SIERECKI
Senior Lecturer
University of New South Wales
Lisa A. Chakrabarti
Université Paris Cité
Jonathan Warrell
Yale University
Pablo Guardado-Calvo
Université Paris Cité
Etienne Decroly
Aix-Marseille University
Luis M Molinos-Albert
Barcelona Institute for Global Health
Emilie Giraud
Institut Pasteur
Cláudio A Franco
Universidade de Aveiro
Oscar Vadas
University of Geneva
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.